Thomas Bartlett

Thomas Bartlett is an experienced patient advocate and consultant specializing in Myasthenia Gravis. Currently serving as a Patient Digital Technology Advisor at argenx and holding various roles such as Myasthenia Gravis Patient Advisor at Johnson & Johnson Innovative Medicine and Myasthenia Gravis Patient Advocate at Amgen, Thomas actively participates in multiple patient advisory councils and advocacy initiatives. With contributions as a writer for Rare Disease Advisor, Thomas also provides marketing consultation through TL Bartlett Consulting and plays a vital role in engaging with legislative efforts for rare diseases in collaboration with organizations like the National Organization for Rare Disorders and Rare Disease Legislative Advocates. Additionally, Thomas possesses extensive background in healthcare market development at DataCore Software. Thomas's education includes studies at New England College.